Allergan settles with one of four companies contesting Restasis patent
October 12, 2017 at 17:41 PM EDT
Oct 12 (Reuters) - Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court.
